These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19175730)
61. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Castagnaro M; De Maria R; Bozzetta E; Ru G; Casalone C; Biolatti B; Caramelli M Res Vet Sci; 1998; 65(3):223-6. PubMed ID: 9915147 [TBL] [Abstract][Full Text] [Related]
62. Effectiveness of ovariohysterectomy on feline mammary fibroepithelial hyperplasia treatment. de Melo EH; Câmara DR; Notomi MK; Jabour FF; Garrido RA; Nogueira AC; Júnior JC; de Souza FW J Feline Med Surg; 2021 Apr; 23(4):351-356. PubMed ID: 32812465 [TBL] [Abstract][Full Text] [Related]
63. Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma. Baxter B Can Vet J; 2017 Jul; 58(7):750-752. PubMed ID: 28698696 [No Abstract] [Full Text] [Related]
64. Platelet count and MCHC as independent prognostic markers for feline mammary carcinomas. da Silva Soares E; Rocha CC; Valente FL; Dos Anjos LRA; de Oliveira FLD; de Oliveira Loures C; Rocha PT; Castro VR; Sarandy TB; Borges APB Res Vet Sci; 2023 Nov; 164():105024. PubMed ID: 37827061 [TBL] [Abstract][Full Text] [Related]
65. Oral mirtazapine decreases the gastrointestinal adverse effects in cats on doxorubicin chemotherapy. Lee CH; Wang SL Vet J; 2024 Apr; 304():106087. PubMed ID: 38395251 [TBL] [Abstract][Full Text] [Related]
66. Clinical characteristics of mammary carcinoma in male cats. Skorupski KA; Overley B; Shofer FS; Goldschmidt MH; Miller CA; Sørenmo KU J Vet Intern Med; 2005; 19(1):52-5. PubMed ID: 15715048 [TBL] [Abstract][Full Text] [Related]
67. What is your diagnosis? Feline mammary fibroepithelial hyperplasia. Sontas BH; Turna O; Ucmak M; Ekici H J Small Anim Pract; 2008 Oct; 49(10):545-7. PubMed ID: 18844825 [No Abstract] [Full Text] [Related]
68. The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma. El-Rasikh AM; Farghali HAM; Abdelrahman HA; Elgaffary M; Abdelmalek S; Emam IA; Ghoneim MA; Selim SA Sci Rep; 2021 May; 11(1):10441. PubMed ID: 34001936 [TBL] [Abstract][Full Text] [Related]
69. Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Wehrend A; Hospes R; Gruber AD Vet Rec; 2001 Mar; 148(11):346-7. PubMed ID: 11316295 [No Abstract] [Full Text] [Related]
70. Surgery and electrochemotherapy treatment of incompletely excised mammary carcinoma in two male pet rats (Rattus norvegicus). Lanza A; Pettorali M; Baldi A; Spugnini EP J Vet Med Sci; 2017 Mar; 79(3):623-625. PubMed ID: 28216544 [TBL] [Abstract][Full Text] [Related]
71. Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin. Kopecny L; Palm CA; Skorupski KA; Delgado M; Rebhun RB J Vet Intern Med; 2020 Sep; 34(5):2048-2055. PubMed ID: 32779764 [TBL] [Abstract][Full Text] [Related]
72. Retrospective evaluation of toceranib phosphate (Palladia) use in the treatment of feline pancreatic carcinoma. Rosario CO; Musser ML; Yuan L; Mochel JP; Talbott J; Johannes CM; Berger EP Can Vet J; 2023 Dec; 64(12):1143-1148. PubMed ID: 38046430 [TBL] [Abstract][Full Text] [Related]
73. Chemotherapy and surgery of spontaneous tumors of mice. 1966. Humphreys SR; Mantel N; Goldin A Eur J Cancer; 2004 Sep; 40(13):1968-73. PubMed ID: 15315805 [No Abstract] [Full Text] [Related]
74. Treatment of fibroadenomatosis in 14 cats with aglepristone - changes in blood parameters and follow-up. Jurka P; Max A Vet Rec; 2009 Nov; 165(22):657-60. PubMed ID: 19946126 [TBL] [Abstract][Full Text] [Related]
75. Anesthesia Case of the Month. Shin CW; Kim H; Han H; Lee I; Son WG J Am Vet Med Assoc; 2017 Aug; 251(4):399-404. PubMed ID: 28763277 [No Abstract] [Full Text] [Related]
76. Cytotoxic effects induced by interferon-ω gene lipofection through ROS generation and mitochondrial membrane potential disruption in feline mammary carcinoma cells. Villaverde MS; Targovnik AM; Miranda MV; Finocchiaro LM; Glikin GC Cytokine; 2016 Aug; 84():47-55. PubMed ID: 27236354 [TBL] [Abstract][Full Text] [Related]
77. Emerging Biomarkers and Targeted Therapies in Feline Mammary Carcinoma. Gameiro A; Urbano AC; Ferreira F Vet Sci; 2021 Aug; 8(8):. PubMed ID: 34437486 [TBL] [Abstract][Full Text] [Related]
78. Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat. Komatsu H; Ueshima A; Kobayashi Y; Shimoyama Y; Takiyama N; Rimpo K Clin Case Rep; 2023 Jun; 11(6):e7582. PubMed ID: 37334334 [TBL] [Abstract][Full Text] [Related]